By Adriano Marchese

 

Eli Lilly & Co. said Wednesday that the U.S. government has purchased 650,000 additional doses of its Bamlanivimab drug in the treatment of Covid-19 for $812.5 million.

The Indianapolis-based company said doses will be delivered through Jan. 31, with at least 350,000 of the additional doses to be delivered in December.

Bamlanivimab recently received emergency-use authorization for the treatment of mild-to-moderate Covid-19 in patients at risk of it progressing to severe.

The order brings the total purchase by the U.S. government to 950,000 doses, the company said.

 

Write to Adriano Marchese at adriano.marchese@wsj.com

 

(END) Dow Jones Newswires

December 02, 2020 16:59 ET (21:59 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.
Eli Lilly (NYSE:LLY)
Historical Stock Chart
From Dec 2020 to Jan 2021 Click Here for more Eli Lilly Charts.
Eli Lilly (NYSE:LLY)
Historical Stock Chart
From Jan 2020 to Jan 2021 Click Here for more Eli Lilly Charts.